SKI Market

A+| A| A-|

Indian Indices

Sensex

74,861.65 302.41
( 0.41%)

Global Indices

Nasdaq

49,785.17 59.69
(0.12%)

Dow Jones

7,421.51 -12.33
(-0.17%)

Hang Seng

63,198.64 456.07
(0.73%)

Nikkei 225

10,253.59 -15.84
(-0.15%)

Forex

USD-INR

95.14 0.72
(0.77%)

EUR-INR

111.99 0.76
(0.69%)

GBP-INR

129.47 0.85
(0.66%)

JPY-INR

0.61 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

22.85

106009.78

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.63

Back

dr reddys laboratories ltd

Dr Reddy's Laboratories consolidated net profit declines 14.42% in the December 2025 quarter

Jan 21,2026

Net profit of Dr Reddy's Laboratories declined 14.42% to Rs 1209.90 crore in the quarter ended December 2025 as against Rs 1413.70 crore during the previous quarter ended December 2024. Sales rose 4.41% to Rs 8727.00 crore in the quarter ended December 2025 as against Rs 8358.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	8727.00	8358.60	4
OPM %	21.63	27.19	-
PBDT	2064.20	2345.70	-12
PBT	1543.20	1874.30	-18
NP	1209.90	1413.70	-14

74,861.65 302.41 ( 0.41%)

49,785.17 59.69 (0.12%)

7,421.51 -12.33 (-0.17%)

63,198.64 456.07 (0.73%)

10,253.59 -15.84 (-0.15%)

95.14 0.72 (0.77%)

111.99 0.76 (0.69%)

129.47 0.85 (0.66%)

0.61 0.00 (0.51%)